Literature DB >> 30611602

Association between social capital and second dose of measles vaccination in Japan: Results from the A-CHILD study.

Nobutoshi Nawa1, Takeo Fujiwara2.   

Abstract

BACKGROUND AND OBJECTIVES: Measles vaccination is important to prevent outbreak, and social capital can be an important preventive factor. However, there have been very few studies that investigated the association between social capital and measles vaccination, especially the second dose, which is more likely to be suboptimal. This study aimed to investigate the association between social capital and second dose of measles vaccine.
METHODS: Data were derived from a population-based study of first-grade elementary school children (6-7 years old) in Adachi City, Tokyo. Caregivers were asked to complete a questionnaire, and 4291 of them provided a valid response (response rate: 80.1%). Among these 4291 valid responses, 69 responses were excluded since variables for social capital measures were missing, which resulted in analytic sample size of 4222. We analyzed the association between measles vaccination and social capital including social ties, social trust and mutual aid by multilevel logistic regression analysis with a random intercept model.
RESULTS: About 8.9% of the children did not receive a second dose of measles-containing vaccines. After covariates adjustments, increase of one-standard-deviation of poor individual-level social ties showed 11% lower odds of receiving measles-containing vaccines (OR: 0.89, 95% CI: 0.80-0.99). By contrast, no significant association between community-level social ties and measles vaccination was found. Regarding social trust, no significant association between individual-level social trust and measles vaccination was found. However, increase of one-standard-deviation of poor community-level social trust showed 11% lower odds of receiving measles-containing vaccines (OR: 0.89, 95% CI: 0.79-0.998). There was no association between mutual aid and measles vaccination.
CONCLUSION: Social ties and social trust were associated with second dose of measles vaccination. Fostering social capital may be effective in raising the low rate of second dose of measles vaccine.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Low immunization rate; Low vaccination rate; Measles-containing vaccines; Social capital; Vaccine acceptance; Vaccine hesitancy

Mesh:

Substances:

Year:  2019        PMID: 30611602     DOI: 10.1016/j.vaccine.2018.12.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States.

Authors:  Byron Carson; Justin Isaacs; Tony Carilli
Journal:  Vaccine       Date:  2022-05-19       Impact factor: 4.169

2.  Mediating role of social capital in the association between socioeconomic status and childcare practices in rural Malawi: a cross-sectional study.

Authors:  Suhyoon Choi; Junko Kiriya; Akira Shibanuma; Masamine Jimba
Journal:  BMJ Open       Date:  2022-05-09       Impact factor: 3.006

3.  Transportation as a barrier to colorectal cancer care.

Authors:  Shelley A Jazowski; Isabelle P Sico; Jennifer H Lindquist; Valerie A Smith; Hayden B Bosworth; Susanne Danus; Dawn Provenzale; Michael J Kelley; Leah L Zullig
Journal:  BMC Health Serv Res       Date:  2021-04-13       Impact factor: 2.655

4.  Facilitators and barriers to physicians' entrepreneurial ventures in major Japanese cities: A qualitative study.

Authors:  Daichi Yashiro; Nobutoshi Nawa; Eriko Okada; Hiroaki Kato; Sarara Yonemori-Matsumoto; Ayako Kashimada; Yasuhiro Itsui; Yujiro Tanaka
Journal:  PLoS One       Date:  2021-10-27       Impact factor: 3.240

5.  Association between grandparent co-residence, socioeconomic status and dental caries among early school-aged children in Japan: A population-based prospective study.

Authors:  Ayako Morita; Yusuke Matsuyama; Aya Isumi; Satomi Doi; Manami Ochi; Takeo Fujiwara
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.